Recombinant factor IX fusion protein benefited untreated patients with hemophilia BAugust 4, 2021Bleeding Disorders
Bleeding events tied to higher mortality in patients with factor V inhibitionJuly 7, 2021Bleeding Disorders
First year of life sees initial bleeding episodes in children with von Willebrand diseaseJune 9, 2021Bleeding DisordersPediatrics
Elevated factor VIII troughs can lead to a higher proportion of zero bleeds in hemophiliaJune 1, 2021Bleeding Disorders
Health costs over 25 times higher for hemophilia B patients than controlsMay 11, 2021Bleeding Disorders
Real-world outcomes of caplacizumab for iTTP comparable to clinical trial resultsApril 7, 2021Bleeding Disorders
Close joint health monitoring essential with new hemophilia therapiesMarch 12, 2021Bleeding DisordersMixed Topics
Bleeding disorder diagnoses delayed by years in girls and womenMarch 9, 2021Bleeding DisordersMixed Topics
